The challenges in implementing open innovation in a global innovation-driven corporation

Research Technology Management

Volumn 55, Issue 4, 2012, Pages 32-38

  Nakagaki, Paul ^a   Aber, Josh ^a   Fetterhoff, Terry ^a  

^a Roche Partnering ^*  (United States)

Author keywords

Innovation culture; Open innovation; Pharmaceutical biotech

Indexed keywords

INNOVATION CULTURE; OPEN INNOVATION; SENIOR MANAGEMENT;

INDUSTRY;

INNOVATION;

EID: 84864137567     PISSN: 08956308     EISSN: 19300166     Source Type: Journal    
DOI: 10.5437/08956308X5504079     Document Type: Article

References (20)

1. Allarakhia, M. 2011. Open Innovation Case Study: GSK's Centres for Excellence in External Drug Discovery. CanBiotech Inc., April. http://www.bioendeavor.net/CommonData/NewsFiles/GSK.pdf.
2. Chesbrough, H. 2011. Pharmaceutical innovation hits the wall: How open innovation can help. Forbes, April 25. http://www.forbes.com/sites/ henrychesbrough/2011/04/25/pharmaceutical-innovation-hits-the-wall-how- openinnovation-can-help/.
3. De Segovia Gross, D. 2010. Can open innovation solve pharma's productivity crisis? [Weblog entry, June 10.] Thinking. Hypios, Inc. http://www.hypios.com/thinking/2010/06/10/can-open-innovation-solve-pharmas- productivity-crisis/.
4. DiMasi, J. A., Hansen, R. W., and Grabowski, H. G. 2003. The price of innovation: New estimates of drug development costs. Journal of Health Economics 22 : 151-185. (Pubitemid 36279392)
5. Haydock, I. 2011. Alliances and open innovation the watchwords as pharma looks to tap Asia's potential. Scrip Intelligence, October 6. http://www.scripintelligence.com/business/Alliances-and-open-innovation-the- watchwords-as-pharma-looksto-tap-Asias-potential-322037.
6. Herper, M. 2011. Rallying pharma's rebels. Forbes, August 22. http://www.forbes.com/forbes/2011/0822/features-bernard-munospfizer-merck- rallying-pharma-rebels.html.
7. Hughes, B. 2009. Harnessing open innovation. Nature Reviews Drug Discovery 8 : 344-345.
8. Jack, A. 2011. Top GSK scientist urges Alzheimer's push. Financial Times, September 4. http://www.ft.com/intl/cms/s/0/ac1d7a0ed6ef-11e0-bc73- 00144feabdc0.html#axzz1sms1NslH.
9. Lyman, S. 2010. The pharmaceutical R&D model is broken. Here's how to fix it. [Weblog entry, March 5.] Xconomy. http://www.xconomy.com/seattle/2010/ 03/05/the-pharmaceuticalrd-model-is-broken-heres-how-to-fix-it/.
10. Melese, T., Lin, S. M., Chang, J. L., and Cohen, N. H. 2009. Open innovation networks between academia and industry: An imperative for breakthrough therapies. Nature Medicine 15 (5): 502-507.
11. Moran, N. 2011. Roche seals its first open innovation agreement in Europe. ScienceBusiness, September 22. http://www.sciencebusiness.net/news/ 75423/Roche-seals-its-firstopen-innovation-agreement-in-Europe.
12. Philippidis, A. 2011. Big pharma's open innovation initiatives zoom in on discovery. Genetic Engineering and Biotechnology News, October 10. http://www.genengnews.com/insight-andintelligenceand153/big-pharma-s-open- innovation-initiativeszoom-in-on-discovery/77899468/.
13. Rufat-Latre, J., Muller, A., and Jones, D. 2010. Delivering on the promise of open innovation. Strategy & Leadership 38 (6): 23-28.
14. RightSite. 2011. Roche and Harvard to cooperate on Suzhou cancer med research. RightSite.asia, November 4. http://rightsite.asia/en/article/roche- and-harvard-cooperate-suzhou-cancermed-research.
15. Roche. 2010. Roche establishes new medical research hub in Singapore. Investor Update, January 28. http://www.roche.com/investors/ir-update/inv- update-2010-01-28b.htm.
16. Scannell, J. W., Blanckley, A., Boldon, H., and Warrington, B. 2012. Diagnosing the decline in pharmaceutical R&D efficiency. Nature Reviews Drug Discovery 11 : 191-200.
17. Sheridan, C. 2011. Industry continues dabbling with open innovation models. Nature Biotechnology 29 (12): 1063-1065.
18. Shields, M., and Pryke, N. 2011. Could open innovation save the pharmaceutical pipeline? Next Generation Pharmaceutical 19 (June). http://www.ngpharma.com/article/Could-open-innovation-save-the- pharmaceuticalpipeline/.
19. Venkataraman, B. 2011. $1 million to inventor of tracker for A.L.S. The New York Times, February 8. http://www.nytimes.com/2011/02/08/health/ 08als.html.
20. Weiss, M., and Drewry, J. 2011. How collaboration enables affordable innovation. CIO, August 29. http://www.cio.com/article/688763/How-Collaboration- Enables-Affordable-Innovation.